Thank you for visiting our website.
We have moved to University College Dublin in 2024!
The Malone Lab is a kidney research group with two main research interests; 1) Transplantation and 2) Glomerular diseases such as FSGS and IgA Nephropathy. I am a transplant/general nephrologist and physician-scientist and worked at Washington University at St Louis for 10 years prior to moving back to Dublin. The WU kidney transplant program is one of the largest in the USA.
In the Malone lab, our goal is to answer important clinical questions affecting patients with transplants or nephrotic syndromes by applying modern experimental techniques to human samples. We use a multiomics approach which includes methods such as scRNA-seq, scATAC-seq, CITE-seq and immune cell profiling as well as single cell imaging methods such as CODEX. We use a mouse model of transplant rejection to complement our human studies. We perform all our own computational analyses in house.
Kidney diseases such as antibody mediated rejection of the transplant and FSGS remain therapeutic challenges. We couple genetics and bioinformatics approaches to investigate how such diseases occur with a view to understanding mechanism, uncovering new markers of disease and treatment targets.
Our team was the first to publish on the application of single cell RNA-seq to human kidney transplant biopsy core samples.
We are now looking for new lab members. If you are interesting in working on single cell methods and computational analysis in transplantation or nephrology please email or DM me: andrew.malone@ucd.ie, @AndrewFMalone
The shift toward lower blood pressure targets has not been adopted in kidney transplant recipients due to unsubstantiated concerns of acute kidney injury. Authors assert that, despite progress toward a blood pressure goal, a target remains elusive. http://bit.ly/KN1704-12…
Nice to see some of my earlier work put to good use in this great publication! Validating splice variants PMID:28013382 @UofTNephrology @med_umontreal
Interesting findings! @UCDMedicine
GLP-1 RAs reduce alcohol intake. Prospective study shows reduction in alcohol intake was 7.1 drinks per week among patients treated with GLP-1 RAs. #dryjanuary
https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.16152
#Budget2025 is this government’s final opportunity to deliver a sustainable funding model for higher education in Ireland. Funding higher education and research is an investment in our country’s future.
@tcddublin @IUAofficial